Molecular imaging reveals skeletal engraftment sites of transplanted bone marrow cells. Academic Article uri icon

Overview

abstract

  • Molecular imaging holds great promise for the in vivo study of cell therapy. Our hypothesis was that multimodality molecular imaging can identify the initial skeletal engraftment sites post-bone marrow cell transplantation. Utilizing a standard mouse model of bone marrow (BM) transplantation, we introduced a combined bioluminescence (BLI) and positron emission tomography (PET) imaging reporter gene into mouse bone marrow cells. Bioluminescence imaging was used for monitoring serially the early in vivo BM cell engraftment/expansion every 24 h. Significant cell engraftment/expansion was noted by greatly increased bioluminescence about 1 week posttransplant. Then PET was applied to acquire three-dimensional images of the whole-body in vivo biodistribution of the transplanted cells. To localize cells in the skeleton, PET was followed by computed tomography (CT). Co-registration of PET and CT mapped the sites of BM engraftment. Multiple, discrete BM cell engraftment sites were observed. Taken together, this multimodality approach may be useful for further in vivo characterization of various therapeutic cell types.

publication date

  • January 1, 2006

Research

keywords

  • Bone Marrow Cells
  • Bone Marrow Transplantation
  • Bone and Bones
  • Luminescent Measurements
  • Positron-Emission Tomography
  • Tomography, X-Ray Computed

Identity

Scopus Document Identifier

  • 33645669162

PubMed ID

  • 16700332

Additional Document Info

volume

  • 15

issue

  • 1